News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
528,716 Results
Type
Article (13217)
Company Profile (150)
Press Release (515259)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (179015)
Career Advice (477)
Deals (27286)
Drug Delivery (14)
Drug Development (56233)
Employer Resources (24)
FDA (10959)
Job Trends (9650)
News (256231)
Policy (20423)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1054)
Academic (1)
Accelerated approval (28)
ADA (19)
Adcomms (1)
Allergies (104)
Alliances (37025)
ALS (115)
Alzheimer's disease (1111)
Antibody-drug conjugate (ADC) (298)
Approvals (11631)
Artificial intelligence (385)
ASCO (181)
Autoimmune disease (218)
Automation (53)
Bankruptcy (274)
Best Places to Work (7587)
BIO (37)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (116)
BioSpace Insights (24)
Biotechnology (96)
Bladder cancer (164)
Brain cancer (31)
Breast cancer (569)
Cancer (4106)
Cardiovascular disease (242)
Career advice (408)
Career pathing (3)
CAR-T (195)
CDC (6)
Celiac Disease (2)
Cell therapy (532)
Cervical cancer (41)
Clinical research (50368)
Collaboration (1460)
Commercialization (3)
Company closure (1)
Compensation (1472)
Complete response letters (35)
COVID-19 (1169)
CRISPR (73)
C-suite (822)
Cystic fibrosis (97)
Data (6046)
Denatured (5)
Depression (104)
Dermatology (64)
Diabetes (372)
Diagnostics (5780)
Digital health (41)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (201)
Drug pricing (11)
Drug shortages (5)
Duchenne muscular dystrophy (176)
Earnings (76088)
Editorial (1)
Employer branding (5)
Employer resources (23)
Events (91894)
Executive appointments (770)
FDA (13813)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1040)
Gene editing (139)
Generative AI (15)
Gene therapy (372)
GLP-1 (385)
Government (1643)
Grass and pollen (3)
Guidances (300)
Healthcare (10532)
Hematology (109)
HIV (59)
Huntington's disease (22)
IgA nephropathy (66)
Immunology and inflammation (106)
Immuno-oncology (60)
Indications (172)
Infectious disease (1393)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (99)
Intellectual property (264)
Interviews (64)
IPO (12880)
IRA (3)
Job creations (2430)
Job search strategy (388)
JPM (6)
Kidney cancer (17)
Labor market (4)
Layoffs (90)
Leadership (3)
Legal (5544)
Licensing (8)
Liver cancer (52)
Longevity (21)
Lung cancer (556)
Lymphoma (291)
Machine learning (32)
Management (7)
Manufacturing (645)
Marketing (8)
MASH (123)
Medical device (9402)
Medtech (9551)
Mergers & acquisitions (15500)
Metabolic disorders (758)
mRNA (68)
Multiple sclerosis (107)
NASH (5)
Neurodegenerative disease (243)
Neuropsychiatric disorders (41)
Neuroscience (2026)
NextGen: Class of 2026 (3572)
Non-profit (1328)
Now hiring (17)
Obesity (239)
Opinion (35)
Ovarian cancer (176)
Pain (178)
Pancreatic cancer (213)
Parkinson's disease (227)
Partnered (20)
Patents (489)
Patient recruitment (524)
Peanut (36)
People (44635)
Pharmaceutical (34)
Pharmacy benefit managers (8)
Phase 1 (16224)
Phase 2 (22288)
Phase 3 (15381)
Pipeline (7865)
Policy (25)
Postmarket research (1746)
Preclinical (7024)
Press Release (42)
Prostate cancer (215)
Psychedelics (7)
Radiopharmaceuticals (208)
Rare diseases (615)
Real estate (4114)
Recruiting (9)
Regulatory (16707)
Reports (22)
Research institute (1097)
Resumes & cover letters (61)
Rett syndrome (42)
RNA editing (5)
RSV (51)
Schizophrenia (102)
Series A (176)
Series B (128)
Service/supplier (5)
Sickle cell disease (64)
Spinal muscular atrophy (95)
Sponsored (11)
Startups (2323)
State (1)
Stomach cancer (4)
Supply chain (63)
Tariffs (1)
The Weekly (1)
Vaccines (386)
Venture capital (18)
Weight loss (87)
Women's health (88)
Worklife (1)
Date
Today (10)
Last 7 days (231)
Last 30 days (1640)
Last 365 days (20350)
2026 (13218)
2025 (20478)
2024 (24639)
2023 (28596)
2022 (37399)
2021 (40333)
2020 (37138)
2019 (26366)
2018 (19797)
2017 (21214)
2016 (20511)
2015 (26670)
2014 (23724)
2013 (20149)
2012 (22139)
2011 (22403)
2010 (21878)
Location
Africa (328)
Alabama (79)
Alaska (3)
Arizona (324)
Arkansas (11)
Asia (21582)
Australia (2888)
California (12348)
Canada (3279)
China (600)
Colorado (506)
Connecticut (426)
Delaware (246)
Europe (35015)
Florida (1831)
Georgia (389)
Hawaii (3)
Idaho (47)
Illinois (757)
India (61)
Indiana (378)
Iowa (16)
Japan (417)
Kansas (113)
Kentucky (41)
Louisiana (34)
Maine (35)
Maryland (1327)
Massachusetts (8194)
Michigan (317)
Minnesota (600)
Mississippi (4)
Missouri (137)
Montana (27)
Nebraska (12)
Nevada (125)
New Hampshire (65)
New Jersey (2863)
New Mexico (18)
New York (2940)
North Carolina (1419)
North Dakota (4)
Northern California (6147)
Ohio (341)
Oklahoma (15)
Oregon (19)
Pennsylvania (2334)
Puerto Rico (22)
Rhode Island (35)
South America (539)
South Carolina (78)
South Dakota (1)
Southern California (5146)
Tennessee (140)
Texas (2016)
United States (40913)
Utah (381)
Vermont (1)
Virginia (168)
Washington D.C. (42)
Washington State (989)
West Virginia (1)
Wisconsin (93)
Wyoming (2)
528,716 Results for "idexx laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
August 11, 2026
·
5 min read
Press Releases
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
January 16, 2026
·
6 min read
Genetown
IDEXX Laboratories Schedules Two Institutional Investor Events
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events.
December 7, 2023
·
1 min read
Genetown
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - February 20, 2024
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming conferences.
February 20, 2024
·
1 min read
Business
IDEXX Laboratories Announces 2023 Third Quarter Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced third quarter results.
November 1, 2023
·
33 min read
Business
IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens.
January 23, 2024
·
1 min read
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
IDEXX Laboratories, Inc. announces the launch of the IDEXX inVue Dx™ Cellular Analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples.
January 12, 2024
·
6 min read
Business
IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, November 1, 2023 before the market opens.
October 5, 2023
·
1 min read
Business
IDEXX Laboratories Announces First Quarter 2023 Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced first quarter results.
May 2, 2023
·
29 min read
Press Releases
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
June 19, 2026
·
1 min read
1 of 52,872
Next
